clinical analysis of 1 125 patients with sle

... hsa-miR -10 6b hsa-miR-20b 4 .11 2.63 2.47 2.43 2. 21 1.93 1. 92 1. 86 1. 86 1. 81 1.76 1. 73 1. 70 1. 66 1. 63 1. 6 1. 48 1. 43 1. 42 1. 33 1. 31 hsa-miR -13 3a hsa-miR-504 hsa-mir-565 hsa-miR -1 hsa-miR- 216 hsa-miR-485-5p ... 716 ± 19 5 62.6 ± 9.9 54 .1 ± 63 .1 5, 215 ± 1, 606 287,485 ± 89,954 13 1,558 ± 35,298 21. 0 ± 13 .0 61. 1 ± 7.5 473 .1 ± 239 11 .1 ± 6.5 10 ,467,524 ± 7,793,493 1, 672 ± 854 93.5 ± 27.8 1, 1 81 ± 10 91 8,4 21 ... 82 ± 26* 200 ± 11 5 377 ± 2 21 2,725 ± 853† 237 ± 61* 566 ± 290† 15 5 ± 67 4 41 ± 443 890 ± 336* 253 ± 10 7* 2, 012 ± 10 88* % Reactive cells CD11b CD15 CD16 CD18 CD177 55 ± 26 21 ± 25 81 ± 22 48 ± 33...

Ngày tải lên: 18/06/2014, 15:20

... Oncology: Official Publication of the International Association for the Study of Lung Cancer 2 010 , 5 :10 91- 1099 doi :10 .11 86 /17 48- 717 X-6-84 Cite this article as: Wu et al.: Clinical Analysis of stereotactic ... 4.638 0 31 895 344 10 .977 0 01 4.5 41 033 10 8 742 10 8 742 002 9 61 5~7 cm 4.638 0 31 10.977 0 01 >7 cm 895 344 4.5 41 033 Wu et al Radiation Oncology 2 011 , 6:84 http://www.ro-journal.com/content/6 /1/ 84 ... value of BED at the isocenter (at 10 0% isodose line) was 19 3.2 Gy (range, 18 4.8~2 01. 6 Gy) in patients with tumor size of ≤3 cm, 19 4.8 Gy (range, 14 2.8~240.0 Gy) in 24 patients with tumor size of...

Ngày tải lên: 09/08/2014, 09:20

... mechanism of self-tolerance causes various autoimmune diseases J Immunol 19 95, 15 5 :11 51- 116 4 O'Garra A, Vieira P: Regulatory T cells and mechanisms of immune system control Nat Med 2004, 10 :8 01- 805 ... CD8+CD28- T cells Int Immunol 19 98, 10 :775-783 Sercarz E, Krzych U: The distinctive specificity of antigen-specific suppressor T cells Immunol Today 19 91, 12 :11 1 -11 8 Morgan ME, Sutmuller RP, Witteveen ... Cyc, Mmf None 15 36/F Er, Ph, Ly V /1 10 GC, Aza Aza 16 25/F Er, Ou, Se, Ly, CNS IV /1 11 GC, Aza, Mtx GC 17 33/F Er, Ph, Ou, Se, Ar, Le IV/8 10 GC, Aza, Mtx, Mmf, Cq GC, Aza, Mtx, Mmf 18 d 28/F Er,...

Ngày tải lên: 09/08/2014, 08:22

... P-value2 Patients without blips Patients with 1 2 blips All patients 30 50 80 37.48 ± 9.93 (16 .83–52.33) 33.30 ± 9.27 (13 .08–53.39) 34.87 ± 9.68 36.02 ± 7.79 (17 .25–45.46) 34.27 ± 7.56 (15 .22–47.59) ... http://www.aidsrestherapy.com/content/3 /1/ 3 Table 1: HIV -1 antibody measurements in HIV -1 infected patients with ≥ five-years undetectable viral load Group N= Average IMx ratio1 at start of HAART, ± st dev (range) ... thirty patients experienced no blips Presumably, patients with blips have a higher mean residual viremia than patients without blips [16 ] Plasma HIV -1 RNA was measured using the VERSANT HIV -1 RNA...

Ngày tải lên: 10/08/2014, 05:20

... 58 76 13 5 32 19 25 45 11 PPAA Normal, < 6° Mild, 6 10 ° Moderate, 11 –20° Severe, ≥ 21 11 6 11 5 63 38 38 21 Results A total of 3 01 dorsoplantar weightbearing radiographs from 17 6 patients with hallux ... 3 01 radiographs Angle Severity No cases Percent HVA Normal, < 15 ° Mild, 15 –20° Moderate 21 39° Severe, ≥ 40° 35 42 15 3 71 12 13 51 24 IMA Normal, < 9° Mild, 9 11 ° Moderate, 12 17 ° Severe, ≥ 18 ° ... editorial assistance References 10 11 12 13 14 15 16 17 18 19 20 21 22 Bettazzoni F, Leardini A, Parenti-Castelli V, Giannini S: Mathematical model for pre-operative planning of linear and closingwedge...

Ngày tải lên: 10/08/2014, 21:23

... fmol/ml 11 7/4 27.36 ± 7.50 3.70 ± 4.63 95.63 ± 18 .54 25.8 ± 13 .5 -0.59 ± 1. 16 239 ± 13 8 358 ± 322 98.90 ± 55.37 0.88 ± 0.24 5/3 31. 63 ± 5.40 4 .12 ± 3.54 92.25 ± 8. 61 3.6 ± 1. 9 -0.05 ± 0.55 15 7 ± ... New Biol 19 91, 4 :14 7 -15 1 Luscher TF: Endothelin J Cardiovasc Pharmacol 19 91, 18 :15 -22 Xu J, Zhong NS: The interaction of tumor necrosis factor alfa and endothelin -1 in pathogenic models of asthma ... 0 .13 ) A statistically significant increase in the concentration of ET -1 in asthmatic patients with EIB was observed (10 after exercise: 1. 64 fmol/ml ± 1. 27, 30 after exercise: 2. 91 fmol/ml ± 1. 18,...

Ngày tải lên: 12/08/2014, 15:21

... ICU: risk factors and outcome evaluated by the SOFA score Intensive Care Med 2000, 26: 915 -9 21 R65 Critical Care 10 11 12 13 14 15 16 17 18 19 20 21 22 23 R66 August 2003 Vol No Rocktaeschel et ... Calcium (mmol/l)a 1. 05 ± 0.40 (mmol/l)*,** 0.88 ± 0.34 0.94 ± 0.28 0.065 1. 10 ± 0 .12 (mmol/l)b,** 1. 12 ± 0.09 1. 17 ± 0.09 0.0009 2.08 ± 0.92 1. 30 ± 0.64 1. 13 ± 0.50 < 0.00 01 Albumin (g/l) 22.6 ... APACHE II score 21. 5 ± 6.3 21. 4 ± 6.2 18 .4 ± 6.9 < 0.05 Serum urea concentration (mmol/l) 24.6 ± 16 .4 8.8 ± 6.0 8.9 ± 5.9 < 0.00 01 314 .9 ± 250.0 11 0.6 ± 70.2 12 8.9 ± 91. 0 < 0.00 01 28 30 18 Not significant...

Ngày tải lên: 12/08/2014, 19:22

... COPAC 30 5.75 1. 41 COWave 30 5.02 1. 04 COTranspulm 30 6. 01 1. 41 Heart rate (beats per minute) 30 81* 13 MAP (mm Hg) 30 73 10 PMAP (mm Hg) 30 21 CVP (mm Hg) 30 PVR (dyn/s per cm-5) 30 12 8 48 SVR ... (mm Hg) 30 19 CVP (mm Hg) 30 PVR (dyn/s per cm-5) 30 18 4 245 cm-5) 30 1, 0 31 342 COPAC 30 4.79 1. 23 COWave 30 4.66 1. 52 COTranspulm 30 4.50 1. 07 Heart rate (beats per minute) 30 76* 12 MAP (mm ... patients [5 ,11 ], showing an accuracy comparable to that of pulmonary artery thermodilution [6 ,11 ,12 ] Recently, a device offering uncalibrated CO measurement by arterial waveform analysis (COWave)...

Ngày tải lên: 13/08/2014, 03:20

... 11 Yes Yes No 4.53 37.8 14 ,10 0 VAP 12 11 Yes No Yes 13 .0 38.2 7,600 Infected pancreatitis 13 14 11 11 Yes Yes No Yes No No 0.833 68.65 38.0 40.0 12 ,700 13 ,200 SBP Enteritis 15 21 Yes Yes No 19 .3 ... (3.7-7.7) (1. 5-4.5) 0. 019 3.5 (3.5-5.7) (6-8) Serum PCT, ng/mL 4.5 (1. 9 -16 .8) 13 (7.9 -19 .3) 0.409 16 .8 (6.2-45.4) 3.05 (6-8) 0. 018 A-sTREM, pg/mL 1, 963 (1, 010 -3 ,12 9 862 (333 -1, 011 ) 0. 019 1, 011 (435-2,274) ... infection 16 248 Negative 227 No 12 15 12 7 Enterococcus faecalis 3,267 Yes 13 11 544 93 Negative 1, 423 Yes SBP 14 15 11 462 34 Negative Negative 2,250 1, 633 Yes Yes Enteritisa SBP 16 17 18 6 Pancreatic...

Ngày tải lên: 14/08/2014, 07:21

... Conflict of interest The authors have declared that no conflict of interest exists Int J Med Sci 2004 1( 1): 1- 10 References 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 WHO Summary of probable ... study of 41 SARS patients treated with a combination of lopinavir/ritonavir and ribavirin compared with 11 1 patients (historical controls) treated with ribavirin only showed that adverse clinical ... 9 :13 81- 7 61 Leung W.K., et al Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection Gastroenterology, 2003 .12 5 :10 11- 1 017 62 Ng E.K., et al Quantitative analysis...

Ngày tải lên: 03/11/2012, 10:20

... Total Patients (％) 734 (32.5) 10 1 (4.5) 33 (1. 5) 10 9 (4.8) 14 5 (6.4) 346 (15 .3) 265 (11 .7) 13 6 (6.0) 11 9 (5.3) 10 4 (4.6) 10 4 (4.6) 95 (4.2) 81 (3.4) 73 (3.2) 64 (2.8) 42 (1. 9) 30 (1. 3) 19 (0.8) 12 ... FBAL-total 1. 22±0.47 Mφ(%) Ly(%) Neu(%) Eo(%) 88.5±3.0 90.5 1. 1 91. 7 1. 2 91. 0 1. 2 4.7 1. 9∗ 1. 5±0.50 0.33±0. 21 1.3±0.33∗ 1. 0±0.45 0.33±0. 21 0.33±0. 21 0.50±0.22 Mφ(%) Ly(%) Neu(%) Eo(%) 85.0±4.6 89.0 1. 2 ... Clin Immunol 19 91; 87 :10 02 -10 0 10 Kawanami O, Ferrans VJ, Fulmer JD, et al Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders Lab Invest 19 79;40: 717 -734 11 Arock M,...

Ngày tải lên: 03/11/2012, 11:48

... structure of four-word terms For instance, in the case of Đao to búa l n, So tính thi t, Noun Phrases 31 18.23 34 18 .48 Adjective Phrases 29 17 .06 40 21. 74 Verb Phrases 10 4 61. 18 11 0 58.78 the ... Disloyalty/ Unfaithfulness 4. 71 11 5.98 11 Stupidity/ Foolishness 4. 71 11 5.98 God because they are Christian In IDHDIE, therefore, “devil” is 12 Silliness/ Clumsiness 14 8.24 16 8.70 used to show bad ... Redman [11 ], semantic opacity is one of the 2.2.5 .1 Overview of Phrase Structure characteristic aspects of idiom of any given language 9 2.2.7 Idioms and Other Language Units 10 A corpus of 17 0...

Ngày tải lên: 26/11/2013, 13:31

... 30.3 36.4 11 .9 36.0 20.8 31. 4

Ngày tải lên: 18/06/2014, 19:20

... (10 .3) 48.2 (11 .1) 47.5 (10 .9) 49.5 (9.5) 49.9 (9.8) 46.0 (11 .8) 47.6 (12 .0) 47.4 (10 .8) 48.2 (10 .6) 48.7 (10 .8) 47.4 (10 .6) 50.2 (9.5) 50.3 (10 .3) 46 .1 (11 .7) 47.4 (12 .0) 47.9 (11 .0) 49.4 (10 .0) ... 51. 3(9.0) 52.3(8.4) 54.3(9.3) 51. 8(8.6) 53.2(9.2) 51. 4(8.5) 51. 3(8.9) 51. 1(9.2) 48.6 (10 4) 49.4 (10 .6) 48.9 (10 .9) 50.2 (9.3) 50.5 (10 .4) 47.2 (10 .9) 48.3 (11 .8) 49 .1 (11 .0) 49.4 (10 .0) 50 .1 ... Placebo (N = 397) P-value1 44 .1 ± 13 .2 266 (32.9) 45.4 ± 13 .4 14 1 (35.5) 0 .11 77 0.3996 0.5432 738 ( 91. 3) 27 (3.3) 21 (2.6) (0.4) 19 (2.4) 358 (90.2) 20 (5.0) (1. 8) (0.3) 11 (2.8) Ethnicity, n (%)2...

Ngày tải lên: 18/06/2014, 19:20

... 670 6 71 6 71 6 71 6 71 6 71 670 670 632 665 669 6 71 69.5 89 .1 75.8 82.9 93.9 77.2 81. 4 91. 3 81. 1 94.6 88.4 84 .1 17.4 15 .2 21. 7 17 .9 12 .9 21. 3 23 .1 17.4 20.7 14 .7 19 .4 13 .5 20.0 – 10 0.0 12 .5 – 10 0.0 ... by ≥ 10 (N = 27–39) 9 .1 (17 .0) 3.3 (16 .9) -0.2 (15 .8) -1. 5 (14 .1) -13 .3 (19 .1) 2.9 (24 .1) 0.7 (14 .2) 1. 8 (22.8) -2 .1 (16 .0) 3.3 (19 .5) 1. 2 (16 .1) 2.4 (19 .2) 2.4 (17 .2) 5 .1 (20.0) -1. 9 (18 .5) ... vision 9 .1 (17 .0) 3.3 (16 .9) -0.2 (15 .8) -1. 5 (14 .1) -13 .3 (19 .1) 5.98***

Ngày tải lên: 18/06/2014, 19:20

... ( 21. 71) 63.27 (18 .47)

Ngày tải lên: 18/06/2014, 19:20

... p-value 19 2 (16 1–239) (7 13 ) 19 (15 –26) 41 (29–50) 36 (29– 41) 25 (20– 31) 31 (24– 41) 10 (8 12 ) 11 (7 13 ) 15 9 (12 8 19 0) (7 14 ) 15 (13 – 21) 28 (23–34) 29 (22–38) 20 (16 –25) 28 (22–35) (6 11 ) 10 (6 12 ) 15 2 ... (10 –77) 44 (23) 63.3 (25 .1) 35.0 (40.3) 58.4 (43.6) 68.0 (19 .8) 73.9 (24 .1) 69.3 (26.6) 60 .1 (22.3) 52.5 ( 21. 4) 44 (20) 11 (17 ) 20 (24) 43 (12 ) 44 (20) 23 (13 ) 29 (11 ) 34 (12 ) 52.5 (20.2) 31. 7 ... (6 12 ) 15 2 (12 6–202) (7 13 ) 15 (12 –22) 25 (20–40) 27 (22–36) 19 (17 –25) 26 (20–33) (6–8) (5 12 )

Ngày tải lên: 18/06/2014, 22:20

... 13 .0–24.0 11 .0 (11 .0 18 .5)2 8.0–29.0 11 .0 (7.8 15 .0) 3.0–29.0 14 .0 (6.5–27.8) 2.0–60.0 4.5 (2.0 12 .5) 1. 0–25.0 1. 3 (1. 1 1. 4) 0. 71 1. 4 14 .5 (12 .0 18 .8 )1 12.0– 21. 0 9.0 (8.5 11 .0)2 7.0 17 .0 25.5 (14 .8–36.5) ... 1. 3 (1. 1 1. 4) 1. 0 1. 7 15 .0 (12 .5 17 .5) 10 .0–23.0 10 .0 (8.5 11 .0) 7.0 12 .0 20.5 (7.3–56.3) 2.0–60.0 32.5 (17 .0–60.0) 5.0–60.0 8.0 (5.8 19 .3) 2.0–32.0 0. 91 (0.74 1. 3) 0.38 1. 4 18 .5 (16 .3–22.5 )1 13.0–24.0 ... Falls within the past months7 Median (range) 66 (59–69) 1. 76 (1. 66 1. 90) 77 (60–95) 18 (10 –22) 37 (15 –70) 3.3 (2.5–4.3), 60 (60–90), 14 5 (10 0 18 5) 3.4 (2.2–4.3), 60 (60–90), 13 0 (10 0 18 5) 11 .7 (10 .4 13 .1) ...

Ngày tải lên: 19/06/2014, 08:20

... Roche 15 16 17 18 19 20 21 22 23 Raychaudhuri SP, Farber EM: The prevalence of psoriasis in the world J Eur Acad Dermatol Venereol 20 01, 15 :16 -17 Lebwohl M: Psoriasis Lancet 2003, 3 61: 119 7 -12 04 ... calcipotriol on the clinical severity and quality of life in patients with psoriasis Br J Dermatol 19 98, 13 9 :10 05 -10 11 Publish with Bio Med Central and every scientist can read your work free of charge ... quality of life in patients with psoriasis" (19 98) [50] Combination of UVB ( 311 nm) and tazarotene vs UVB ( 311 nm) plus calcipotriol or vice versa PASI No significant differences in QoL of patients...

Ngày tải lên: 20/06/2014, 15:20

... for Diseases of the Esophagus Dis Esophagus 19 96, 9:s3 -19 Page of (page number not for citation purposes) Health and Quality of Life Outcomes 2006, 4:45 12 13 14 15 16 17 18 19 20 21 22 23 24 25 ... quality of life measure because it incorporates all aspect of health into a single number (between and 1) with the extreme endpoints of death and perfect health [16 ] Methods Patients Patients with ... of barrett's esophagus with high-grade dysplasia Gastroenterology 20 01, 12 0(7) :16 07 -16 19 Overholt BF, Panjehpour M, Haydek JM: Photodynamic therapy for Barrett's esophagus: follow-up in 10 0 patients...

Ngày tải lên: 20/06/2014, 15:20